Red Clover Supplements Manufacturer

Our specification review starts with the botanical identity, plant part, extract type, and assay method. For standardized programs, the isoflavone profile can be characterized by HPLC, including daidzein, genistein, formononetin, and biochanin A.

Finished-product release requirements are established against the approved BOM and project specification, with batch-specific COA documentation available according to the agreed testing scope.

The main difference is the concentration of the specified isoflavone markers.

For example, a 40 mg isoflavone target would theoretically require approximately:

• 500 mg of an 8% extract
• 200 mg of a 20% extract
• 100 mg of a 40% extract

This is feasibility math, not a recommended dosage. Actual fill weight depends on bulk density, flowability, excipients, and the finished dosage form.

The extract grade should therefore be selected together with the target dose and format, rather than independently.

Yes. Red clover can be developed in several finished-product formats, including hard capsules, tablets, gummies, powders/sticks, and project-specific liquid formats.

Capsules and tablets are generally more suitable when the formula requires a relatively concentrated isoflavone load. Gummies can be developed when the commercial concept prioritizes taste and consumer experience, but the achievable active load per serving needs to be assessed during formulation.

Dry red clover extract is not treated as a conventional softgel fill; when oil-phase ingredients such as evening primrose oil are required, we can evaluate a capsule + softgel dual-SKU structure.

Yes. A soy-free concept can be developed with red clover as the sole isoflavone source.

Soy-free control should be based on the approved BOM, raw-material specifications, supplier documentation, allergen review, and project-specific testing where required. The red clover HPLC profile helps characterize the botanical but is not, by itself, a standalone soy-free certification.

Yes. Common development directions include red clover combined with black cohosh, soy isoflavones, calcium, vitamin D3, vitamin K2, evening primrose oil, and other ingredients depending on the target market and product concept.

For complex formulas, we assess ingredient compatibility, total fill weight, serving size, dosage form, processing requirements, and destination-market considerations before sampling.

Yes. A final formula does not need to be locked before the initial inquiry.

You can provide your target market, sales channel, positioning, preferred format, target volume, and launch timing. Our formulation team can then recommend a specification path, extract grade, formula architecture, dosage-form direction, and preliminary fill feasibility before sampling.

This is the concept-to-SKU development route.

For the most comparable quotation, provide:

• Target market and country
• Sales channel
• Product positioning
• Preferred dosage form
• Red clover extract specification, if available
• Target isoflavone amount per serving, if known
• Formula or preferred ingredients
• Initial order quantity
• Packaging requirements
• Target launch date
• Required certifications or testing

If some specifications are not available, send the product concept instead. We can help define the missing parameters before quotation.

For capsule and tablet projects, the typical MOQ is 3,000–5,000 finished units, subject to formula, packaging, and project requirements.

Typical timing:

• Sample: 7–15 days after specification confirmation
• Mass production: approximately 4–6 weeks after sample approval

Complex formulas, special packaging, additional testing, or peak production periods may require additional time.

Depending on the project, documentation can include:

• Raw-material COA
• Finished-product COA
• Red clover identity and HPLC assay information
• Allergen statement
• Microbiological testing
• Heavy-metal testing
• Pesticide testing
• Residual-solvent testing where applicable
• Product specification
• Stability documentation where available and applicable

The exact release and documentation package is agreed during specification review and based on the destination market.

Yes. After the key specification and formulation requirements are confirmed, we can prepare a development sample for evaluation.

Where applicable, the sample process can include the relevant raw-material or finished-product COA documentation so your R&D, QA, or procurement team can review the material against the agreed specification before commercial production.

Yes, projects can be developed for different target markets, but the formula and label should be reviewed against the specific destination country’s regulatory requirements.

Before sampling, we recommend locking the target market because ingredient forms, permitted claims, dosage considerations, allergen requirements, testing requirements, and labeling rules can differ between markets.

KS Nutripharma provides manufacturing and documentation support; the brand owner and its regulatory counsel remain responsible for final market authorization and label compliance.

Before sample approval, we recommend confirming these seven items:

Species → Plant part → Extract type → HPLC specification → Target amount/serving → Dosage form → Target market

Once these are locked, we can assess fill feasibility, formula architecture, testing requirements, quotation, and sample development with much less risk of reformulation later.